Hypothyroidism is a clinical syndrome caused by a deficiency of thyroid hormones or their tissue resistance. The thyroid gland relies on adequate dietary iodine to synthesize thyroxine (T4) and triiodothyronine (T3). Under the control of the hypothalamus-pituitary-thyroid axis, thyrotropin-releasing hormone stimulates the anterior pituitary to release thyroid-stimulating hormone (TSH). TSH then prompts the thyroid gland to produce and release T4 and T3 into the bloodstream. When hormone levels drop, the pituitary releases more TSH to stimulate the gland. In primary hypothyroidism, the gland itself fails, leading to low T4 and elevated TSH levels. Common signs in clinical practice include fatigue, cold intolerance, weight gain, bradycardia, and dry skin.
Pharmacological management of hypothyroidism centers on replacing deficient hormones with synthetic or natural preparations.
Levothyroxine mimics endogenous thyroxine. Following oral administration, absorption occurs primarily in the small intestine, though absorption can be impaired by food, fiber, and various medications. Once absorbed, more than ninety-nine percent of circulating levothyroxine binds to plasma proteins, leaving a tiny fraction free to enter cells. In peripheral tissues, enzymes called deiodinases convert T4 into the active T3 hormone. Levothyroxine has a long plasma half-life of approximately seven days, allowing for once-daily dosing and requiring several weeks to reach steady-state serum concentrations.
Levothyroxine is indicated for primary hypothyroidism, congenital hypothyroidism, and thyroid-stimulating hormone suppression in thyroid cancer. Dosing must be individualized based on patient age, body weight, and cardiovascular status. Elderly patients or those with coronary artery disease start on much lower doses to prevent myocardial ischemia. The standard approach follows a 'start low and go slow' rule, with dose titration guided by periodic TSH testing every six to eight weeks. Administration requires consistency: patients should take the tablet orally on an empty stomach with a full glass of water, ideally thirty to sixty minutes before breakfast, to maximize gastrointestinal absorption.
Over-replacement of thyroid hormone results in iatrogenic hyperthyroidism, presenting with symptoms such as tachycardia, palpitations, tremors, nervousness, heat intolerance, and weight loss. Chronic over-treatment in older adults increases the risk of atrial fibrillation and accelerated bone mineral loss leading to osteoporosis. Drug interactions frequently compromise levothyroxine efficacy. Calcium carbonate, ferrous sulfate, and antacids bind to thyroid hormone in the gut, drastically reducing absorption. Conversely, drugs that induce hepatic enzymes, such as rifampicin or phenytoin, speed up the clearance of thyroid hormones from the body.
Nurses play a critical role in managing patients with hypothyroidism across Nigerian healthcare settings. Assessment involves checking vital signs, evaluating weight changes, and noting energy levels and bowel habits. Nurses must educate patients on the necessity of lifelong therapy, warning them against stopping medication when symptoms improve. In many local communities, patients may turn to herbal remedies or dietary supplements that can interact with conventional therapy; nurses should inquire about these practices non-judgmentally. Laboratory monitoring of TSH levels remains central to evaluating therapeutic success, ensuring the dose remains safe and effective over time.